Clinical trials: Instructions for Use
Alzheimer's Type Dementia
Intensive Instruction on the Use of Aricept
The purpose of this study is to examine the influence of the instruction on the use of Aricept with educational brochure on the 48-week medication persistence and to assess the reasons for discontinuation.
- Trial name
- NCT01972204
- Testing
- Intensive adherence instruction, Control
- Where
- Japan
- Volunteers
- 125 people
- Sponsor
- Mirai Iryo Research Center, Inc.
Cystic Fibrosis
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
The purpose of this actual use human factors (HF) study is to validate the approved US TOBI Podhaler Instructions for Use (IFU), by establishing that the IFU effectively communicates the information necessary to achieve safe and…
- Trial name
- NCT02178540
- Testing
- Tobi Podhaler
- Where
- 13 sites in United States
- Volunteers
- 45 people
- Sponsor
- Novartis Pharmaceuticals